Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
McIlvride, SaraidNikolova, Vanya
Fan, Hei Man
McDonald, Julie A K
Wahlström, Annika
Bellafante, Elena
Jansen, Eugene
Adorini, Luciano
Shapiro, David
Jones, Peter
Marchesi, Julian R
Marschall, Hanns-Ulrich
Williamson, Catherine
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes.Published in
Am J Physiol Endocrinol Metab 2019;317(2):e399-410PMID
31237448ae974a485f413a2113503eed53cd6c53
10.1152/ajpendo.00407.2018
Scopus Count
Collections
Related articles
- Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia.
- Authors: Pataia V, McIlvride S, Papacleovoulou G, Ovadia C, McDonald JAK, Wahlström A, Jansen E, Adorini L, Shapiro D, Marchesi JR, Marschall HU, Williamson C
- Issue date: 2020 Aug 1
- Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
- Authors: Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D
- Issue date: 2013 Sep
- Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH.
- Authors: Carino A, Biagioli M, Marchianò S, Fiorucci C, Zampella A, Monti MC, Scarpelli P, Ricci P, Distrutti E, Fiorucci S
- Issue date: 2019 Oct
- Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.
- Authors: Jouihan H, Will S, Guionaud S, Boland ML, Oldham S, Ravn P, Celeste A, Trevaskis JL
- Issue date: 2017 Nov
- Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
- Authors: Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M
- Issue date: 2018 Jan 14